Trebicka, J.

patient level study thrombosis factor control plasma liver venou venous thrombosis protein portal syndrome disorder anticoagulation sample hospital signi blood diagnosis signi ficantly result plasma levels budd-chiari syndrome mutation hepatic inhibitor 1 levels recanalization obstruction analysis hepatology disease portal vein risk factor treatment portal vein thrombosis identi fied budd –chiari syndrome ascite month range number activity brinogen brinolytic university therapy fi brinogen budd-chiari rotterdam imaging survival bcs patients anticoagulation therapy fxiii center identi ficantly t-pa antigen plasma samples fi brinolysis value plasminogen abundance group difference erasmus mc follow-up function fi brinolytic system polymorphism splenic plasminogen activator inhibitor activator valla brinolysi bcs-patient haplotype plasmin